Hi Dee,
The presentation could be something or it could be nothing, let's see what they are going to share.
Noxopharm’s presentation abstract will also be published in Lupus Science & Medicine, the official journal of the Lupus Foundation of America.
At the moment all we have is hope that they can turn it around, Plan for the worst case scenario and hope for a better outcome.
Ann: Change of Director's Interest Notice - FB, page-34
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $15.23K | 145.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7857 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |